-
"It's too bad someone didn't give you thrombolytics, because you probably wouldn't be paralyzed now." Whether it's a nurse, doctor, or someone else making that statement to a stroke patient cared for in your ED, you could end up named in a lawsuit.
-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
In this paper, Khairy and colleagues from the Alliance for Adult Research in Congenital Cardiology (AARCC) conducted a multi-center, cross-sectional study on the prevalence of arrhythmias in adult patients who had previously undergone surgical repair of either tetralogy of Fallot or pulmonary atresia with ventricular septal defect.
-
-
In October 2009, the FDA licensed the bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years.
-
Initial association analysis was performed on 205 african-americans with biopsy-proven FSGS and 180 African-American controls.
-
-
In this issue: FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
Although there is little data to support this, I routinely counsel my HIV-infected patients to get seasonal and H1N1 vaccine, explaining that while they are probably at no greater risk for "catching the flu," they may be at greater risk for more severe symptoms and complications than someone without HIV.
-
A 39-year-old man had traveled for four weeks to the Pantanal region of Brazil, a popular ecotourism area, where he had walked barefoot on several occasions.